Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities

Arnon P. Kater, Carolyn Owen, Carol Moreno, +18

NEJM Evidence

ImmunologyPathologyFixed-duration Ibrutinib-venetoclaxPharmacotherapyImmunotherapy +14

Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes

Ohad Benjamini, Preetesh Jain, Long Trinh, +11

Leukemia & lymphoma/Leukemia and lymphoma

Hematological MalignancyTumor BiologyLymphoid NeoplasiaChronic Lymphocytic LeukemiaMedicine +12

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

Yair Herishanu, Galia Rahav, Shai Levi, +9

Blood

Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial

Carsten Utoft Niemann, Talha Munir, Carol Moreno, +20

The Lancet Oncology

Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukaemiaMedicineHematology +8

The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression

Michal Abraham, Shiri Klein, Baruch Bulvik, +14

Leukemia

MedicineApoptosisImmunologyAml BlastsCell Death +6

Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib

Dominik Wodarz, Naveen Garg, Natalia L. Komarova, +7

Blood

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Ohad Benjamini, Lior Rokach, Gilad Itchaki, +15

Haematologica

VaccinationVaccine SafetyVaccinologyVaccine DevelopmentChronic Lymphocytic Leukemia +11

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies

Shiri Weinstein, Itai Antoine Toker, Rafi Emmanuel, +11

Proceedings of the National Academy of Sciences

Cell-based Drug DeliveryNanomedicineDrug TargetingNovel TherapyMedicine +12

Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational study

Rosa Ruchlemer, Ronen Ben‐Ami, Maskit Bar‐Meir, +26

Mycoses

BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study

Galia Rahav, Yaniv Lustig, Jacob Lavee, +16

EClinicalMedicine